ISB News

COVID-19 Vaccines and Boosters Are Essential for Maternal-Fetal Health

In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters. 

In research published in Lancet Digital Health, researchers from the Institute for Systems Biology showed two important findings: 

  • Vaccinated pregnant people are less likely to have poor birth outcomes like preterm birth, stillbirth, or very low birth weight (below 3.3 pounds) compared to unvaccinated pregnant people, and those who had a booster are even less likely to have stillbirth compared to those vaccinated without boosters.
  • Pregnant people who are vaccinated are less likely to contract COVID-19 than unvaccinated pregnant people, and those vaccinated and boosted are less likely to get COVID than those who are vaccinated only.

Three of the research paper’s authors said the following:

“The take-home message is COVID-19 vaccination is associated with better maternal-fetal outcomes, and boosters are associated with further reduced rates of stillbirth.” 

– Jennifer Hadlock, MD, Associate Professor and Director of Medical Data Science, Institute for Systems Biology

“We found that vaccinated pregnant people had lower COVID-19 rates than those who were unvaccinated, and that the pregnant people who were vaccinated and boosted had even lower rates” 

Samantha Piekos, PhD, Research Scientist and K. Carole Ellison Fellow in Bioinformatics, Institute for Systems Biology

“I cite this data to my patients. Vaccines and boosters help keep mom and baby safe.” 

– Tanya Sorensen, MD, Executive Medical Director, Women and Children’s Institute and Acute Care Services, Providence Swedish

This research builds on the authors’ previously published study that showed even mild cases of COVID-19 during pregnancy can increase risk for poor birth outcomes.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.